Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Drug Payment Demonstration May Advance In 2023 Under Executive Order

Executive Summary

Demonstration would ‘build on’ Medicare price controls established by the Inflation Reduction Act, White House says.

You may also be interested in...



Republican Leaders In Congress Want To Undercut Drug Pricing Law: What’s The Opportunity?

As Republicans expand their power in Congress, experts weigh in on prospects for significant changes to the Medicare price negotiation law and what the GOP might do to hamper implementation of the program.

Another Drug Pricing Executive Order?!

President Joe Biden defines himself as the opposite of Donald Trump. But they appear to share a fondness for Executive Orders on drug pricing.

US Price Control, Outcomes-Based Contracting: Reflections Of Former VA Secretary Shulkin

The former Secretary of the US Department of Veterans Affairs, David Shulkin, discusses in an interview the US Inflation Reduction Act, telehealth, interoperability of healthcare data, and Mark Cuban’s pharma venture.

Related Content

Latest News
See All
UsernamePublicRestriction

Register

PS147159

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel